Replay available

MediWound Ltd. (MDWD) Q2 2026 Earnings Call

MediWound Ltd. (NASDAQ: MDWD) Q2 2026 earnings conference call, held 2026-08-13. Replay captured from the company's public earnings webcast.

Thu, August 13, 2026 at 8:30 AMendedReplay
MediWound Ltd. (MDWD) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Gaia Shamus

LifeSci Advisors

Ofer Gonen

Chief Executive Officer, MediWound

Hani Luxenburg

Chief Financial Officer, MediWound

Barry Wolfenson

Executive Vice President of Strategy and Corporate Development, MediWound

R.K. Ramakant

Analyst, HC Wainwright

Josh Jennings

Analyst, TD Cowen

Jeff Jones

Analyst, Oppenheimer

Chase Knickerbocker

Analyst, Craig Hallum

Michael Okunetch

Analyst, Maxim Group

Scott Henry

Analyst, Alliance Global Partners

Replay transcript excerpt

Good day and welcome to the MediWound second quarter 2026 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Gaia Shamus from LifeSci Advisors. Please go ahead. Thank you, Chloe, and welcome everyone. Earlier today, pre-market open, MediWound issued a press release announcing financial results for the second quarter ended June 30th, 2026. You may access this press release on the company's website under the investor tab. I would ask you to review the full text of our forward-looking statements within this morning press release. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to MediWound's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from expectations and are described more fully in our filings with the SEC. In addition, all forward-looking statements represent our views only as of today, and MediWound assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events, or otherwise. This conference call is property of MediWound and any recording or rebroadcast is expressly prohi...

More from Mediwound Ltd.